Is Lockheed Martin Stock Worth Buying Before Q2 Earnings Release?

This is less a clean beat/miss setup than a credibility test on the margin bridge. The market is likely willing to look through a middling quarter only if management shows that the second-half ramp is translating into cash, not just units; otherwise, the current discount can persist because backlog visibility does not automatically convert into ROIC or EPS re-rating. In other words, the real variable is not revenue growth but whether fixed-price program risk is finally shrinking fast enough to change the 2027-2028 earnings base.

Relative value favors the cleaner execution stories. If LMT merely reaffirms without accelerating margin repair, capital should keep rotating toward RTX and, to a lesser extent, NOC, where the earnings setup is more favorable and the market is paying less for uncertainty. A miss or a cautious guide would also pressure missile and air-defense sub-tier suppliers tied to LMT execution, while peers with similar demand exposure but better delivery cadence can absorb share and investor flows.

The contrarian point is that LMT is already de-rated, so an outright short has limited convexity unless guidance disappoints. The better risk/reward is hedged: the immediate reaction may be modest, but the 1-3 month catalyst is whether Q3/Q4 commentary confirms the margin inflection; over 6-18 months, the key question is whether production additions actually lift free cash flow and not just backlog. Falsifiers are explicit: a guide-up in FY EPS/FCF, a sharper-than-expected margin step-up, or evidence that working capital is normalizing faster than expected.